Ethical Aspects of ctDNA-based Multi-Cancer Screening
Author Information
Author(s): Wybo Dondorp, Guido de Wert
Primary Institution: Maastricht University
Hypothesis
What are the ethical implications of using ctDNA for multi-cancer screening?
Conclusion
The study highlights the need to consider ethical challenges in the development of ctDNA-based multi-cancer screening.
Supporting Evidence
- MCED tests need validation in large-scale studies.
- Ethical challenges include the potential for harm and overdiagnosis.
- Screening should have defined objectives and minimize risks.
Takeaway
This study talks about using a blood test to find many types of cancer early, but we need to think about the ethical issues that come with it.
Methodology
The paper explores ethical aspects of ctDNA-based multi-cancer screening through a review of existing literature and ethical frameworks.
Potential Biases
Potential for false reassurance and overdiagnosis due to low sensitivity of current tests.
Limitations
The study does not provide empirical data from large-scale validation studies yet.
Participant Demographics
Non-patient populations aged 50 to 79 for the GALLERI test pilot.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website